NEW YORK, June 11 (Reuters) - Some employers are planning to drop coverage of GLP-1 drugs for weight loss next year as more people take the medications, counteracting some savings from lower prices ...
But many investors are feeling doubtful and anxious along with the exuberance of this bull market. Are AI stocks too richly valued? What if corporate spending on AI capital expenditures slows? What if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results